about
Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence TherapyVirulence Plasmids of Nonsporulating Gram-Positive PathogensCase-control study of risk factors for infectious mastitis in Spanish breastfeeding women.Genome sequencing of multidrug resistant novel Clostridium sp. BL8 reveals its potential for pathogenicityHumanized staphylococcal enterotoxin B (SEB)-specific monoclonal antibodies protect from SEB intoxication and Staphylococcus aureus infections alone or as adjunctive therapy with vancomycinSubpopulations of Staphylococcus aureus clonal complex 121 are associated with distinct clinical entitiesDendritic cells during Staphylococcus aureus infection: subsets and roles.Prevalence and characterization of methicillin-resistant Staphylococcus aureus isolates from healthy university student athletesPredominant Dissemination of PVL-Negative CC89 MRSA with SCCmec Type II in Children with Impetigo in Japan.Distribution of toxin genes among different spa types and phage types of animal Staphylococcus aureus.Detecting Staphylococcus aureus Virulence and Resistance Genes: a Comparison of Whole-Genome Sequencing and DNA Microarray TechnologyHigh Prevalence of Exfoliative Toxins Among Carrier Isolates of Staphylococcus aureus from Healthy Individuals from Various Communities in Chennai, South India.Staphylococcus aureus toxins.Three-Dimensional Human Skin Models to Understand Staphylococcus aureus Skin Colonization and InfectionStaphylococcus aureus mobile genetic elements.Glutamyl Endopeptidases: The Puzzle of Substrate SpecificityEmergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.Elucidating the anti-Staphylococcus aureus antibody response by immunoproteomics.Surface and Exoproteomes of Gram-Positive Pathogens for Vaccine Discovery.Staphylococcus aureus, phagocyte NADPH oxidase and chronic granulomatous disease.Autocatalytic activation of a thermostable glutamyl endopeptidase capable of hydrolyzing proteins at high temperatures.Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention.C55 bacteriocin produced by ETB-plasmid positive Staphylococcus aureus strains is a key factor for competition with S. aureus strains.Genetic Determinants of Methicillin Resistance and Virulence among Staphylococcus aureus Isolates Recovered from Clinical and Surveillance Cultures in a Brazilian Teaching Hospital.Clustering of Staphylococcus aureus bovine mastitis strains from regions of Central-Eastern Poland based on their biochemical and genetic characteristics.Diversity of Virulence Factors Associated with West Australian Methicillin-Sensitive Staphylococcus aureus Isolates of Human Origin.Cell-Cell Junctions Organize Structural and Signaling Networks.Histopathology, microbiology and the inflammatory process associated with Sarcoptes scabiei infection in the Iberian ibex, Capra pyrenaica.An outbreak of skin infections in neonates due to a Staphylococcus aureus strain producing the exfoliative toxin A.High Production of LukMF' in Staphylococcus aureus Field Strains Is Associated with Clinical Bovine Mastitis.Activity of antimicrobial peptides and conventional antibiotics against superantigen positive Staphylococcus aureus isolated from patients with atopic dermatitis.Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases.Joint Genomic and Proteomic Analysis Identifies Meta-Trait Characteristics of Virulent and Non-virulent Staphylococcus aureus Strains.Bacterial Toxins - Structure, Properties and Mode of Action
P2860
Q26752975-113A627D-6C26-4E90-ADBE-2253AC6E4FA2Q28085472-D6343B2B-AE23-4FB7-8472-082945824DB1Q33776684-A02BC814-1572-40C6-B7E7-98FEF57FFBE2Q33971615-99D751FB-7CB2-4CC3-B980-78CBF6D736DAQ34315661-CB247795-48C6-4E7C-8385-97FBB89B9EE8Q34625626-F1D8D0C6-C0BB-4738-BDC3-6F3B19D3B6B4Q34788587-B3767976-ACC7-4045-B943-8AE5E4AA35AEQ35183835-E367B656-E250-4400-A9C3-F56F7724D93BQ35609122-2A336D10-FC15-47D9-AAE9-1D9FF9C771C7Q35952573-3C536B50-DF69-49FE-9EEE-984B0025CC5CQ36734929-42798851-F3E1-41C9-B517-0348A3084DE5Q36946345-08A6BB46-6A5D-411F-B987-0D02A05FFD91Q37617576-55E0A4A1-6A5B-494C-BBD6-B91B74344B05Q38190950-3813F9B3-DD12-4A24-AA95-373C47FE8E13Q38204276-85BD78FD-87FB-495C-A675-FF04C05DDD37Q38663294-4405C527-4FE8-49C8-AAC7-651C2335A022Q38737568-66CEA624-6F1B-4E94-AB3A-65B1E8354ADDQ38924957-23D496D4-0090-4111-9831-2D90B2546020Q38958617-E04E3977-95A3-4D53-BAFD-01F923208569Q39037945-BAD11BD5-F6E6-4FCF-85CC-5934FCF539C9Q40667582-752C5A1F-D084-4D56-9D0C-77909DB0FDF0Q40697398-4AA0C22F-6620-4596-BA4F-480A1DE97926Q40821156-73D067CC-0102-456D-9C69-BB4F26C539B6Q40853391-496E1FB3-4DF0-42BB-88A5-A2268155F000Q41109474-355CD5F3-ED54-4CF9-B785-6B52F6610DF3Q42770328-FA08D6EE-BC7D-43D3-9517-1208A89DB981Q44912536-5E14D2A4-AE41-4419-92E8-96488B740788Q47098633-76EC5200-BA92-48D1-983F-3F1A3BA6403EQ50129601-03F42292-9EC1-4FC5-93CB-AE9FB7E23359Q53681971-2276F5D5-E6B1-44C7-9FD4-3BB0B561A74BQ53700112-5FA8C376-D34D-4B5A-B8A9-A2A0F2BBDAC6Q55515231-E05C1B9D-5627-4390-8592-9081AF353D7AQ58761353-C1CA360C-A2F2-46B6-9F76-5C65E2D0EBC9Q58834190-B5FD0985-D7C3-46C5-82B0-69573B160E32
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Exfoliative toxins of Staphylococcus aureus
@ast
Exfoliative toxins of Staphylococcus aureus
@en
type
label
Exfoliative toxins of Staphylococcus aureus
@ast
Exfoliative toxins of Staphylococcus aureus
@en
prefLabel
Exfoliative toxins of Staphylococcus aureus
@ast
Exfoliative toxins of Staphylococcus aureus
@en
P2860
P356
P1433
P1476
Exfoliative toxins of Staphylococcus aureus
@en
P2093
Michal Bukowski
P2860
P304
P356
10.3390/TOXINS2051148
P577
2010-05-01T00:00:00Z
2010-05-25T00:00:00Z